News

AddToAny

Google+ Facebook Twitter Twitter

"HIV vaccine design shows promise"

A novel protein-sugar vaccine candidate has stimulated an immune response against sugars that form a protective shield around HIV.

It has been tested in an animal model and it is hoped that the molecule could one day become part of a successful HIV vaccine.

Lai-Xi Wang, one of the researchers working on the project, said: “An obstacle to creating an effective HIV vaccine is the difficulty of getting the immune system to generate antibodies against the sugar shield of multiple HIV strains. Our method addresses this problem by designing a vaccine component that mimics a protein-sugar part of this shield.”

The researchers, from the University of Maryland and Duke University, designed a vaccine candidate using an HIV protein fragment linked to a sugar group.

When injected into rabbits, the vaccine candidate stimulated antibody responses against the sugar shield in four different HIV strains.

bit.ly/BS_DecNews1

Related Articles

Four decades of tuberculosis

Professor Douglas Young discusses the last 40 years of tuberculosis research, as he hangs up his lab coat for the final time.

Chemo-boosting Drug

Drugs developed to treat heart and blood vessel problems could be used in combination with chemot

Indirect Carbapenemase test

Of increasing concern is the level of carbapenem resistance amongst Gram-negative bacteria caused

Top